Cited by 2,586Nanoparticle-Based Drug DeliveryNanotechnology research and applicationsAdvanced Drug Delivery Systems

The DOI matches its Crossref record; 91 of the 94 references it cites were found in a registry or an index.

Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date

Bobo, Daniel, Robinson, Kye J., Islam, Jiaul, Thurecht, Kristofer J., Corrie, Simon R.·2016·Pharmaceutical Research

DOI 10.1007/s11095-016-1958-5

Open this paper in CoChat — free account

Abstract

In this review we provide an up to date snapshot of nanomedicines either currently approved by the US FDA, or in the FDA clinical trials process. We define nanomedicines as therapeutic or imaging agents which comprise a nanoparticle in order to control the biodistribution, enhance the efficacy, or otherwise reduce toxicity of a drug or biologic. We identified 51 FDA-approved nanomedicines that met this definition and 77 products in clinical trials, with ~40% of trials listed in clinicaltrials.gov started in 2014 or 2015. While FDA approved materials are heavily weighted to polymeric, liposomal, and nanocrystal formulations, there is a trend towards the development of more complex materials comprising micelles, protein-based NPs, and also the emergence of a variety of inorganic and metallic particles in clinical trials. We then provide an overview of the different material categories represented in our search, highlighting nanomedicines that have either been recently approved, or are already in clinical trials. We conclude with some comments on future perspectives for nanomedicines, which we expect to include more actively-targeted materials, multi-functional materials ("theranostics") and more complicated materials that blur the boundaries of traditional material categories. A key challenge for researchers, industry, and regulators is how to classify new materials and what additional testing (e.g. safety and toxicity) is required before products become available.

Integrity signals

Registry

Crossref · 10.1007/s11095-016-1958-5

Cites

91 of 91 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 retracted

RETRACTED: MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer
Taylor, D. D., & Gerçel-Taylor, Ç. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.04.033 · Cited by 2,333
Retracted
Understanding biophysicochemical interactions at the nano–bio interface
Nel, A. E., Mädler, L., Velegol, D., Xia, T., Hoek, E. M. V., Somasundaran, P., Klaessig, F., Castranova, V., & Thompson, M. (2009) · Nature Materials · doi:10.1038/nmat2442 · Cited by 7,083
Principles of nanoparticle design for overcoming biological barriers to drug delivery
Blanco, E., Shen, H., & Ferrari, M. (2015) · Nature Biotechnology · doi:10.1038/nbt.3330 · Cited by 7,002
Liposomal drug delivery systems: From concept to clinical applications
Allen, T. M., & Cullis, P. R. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.037 · Cited by 4,839
Diffusion of univalent ions across the lamellae of swollen phospholipids
Bangham, A. D., Standish, M. M., & Watkins, J. C. (1965) · Journal of Molecular Biology · doi:10.1016/s0022-2836(65)80093-6 · Cited by 4,664
Renal clearance of quantum dots
Soo Choi, H., Liu, W., Misra, P., Tanaka, E., Zimmer, J. P., Itty Ipe, B., Bawendi, M. G., & Frangioni, J. V. (2007) · Nature Biotechnology · doi:10.1038/nbt1340 · Cited by 4,476
The Effect of Nanoparticle Size, Shape, and Surface Chemistry on Biological Systems
Albanese, A., Tang, P. S., & Chan, W. C. W. (2012) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071811-150124 · Cited by 3,996
Factors affecting the clearance and biodistribution of polymeric nanoparticles
Alexis, F., Pridgen, E., Molnar, L. K., & Farokhzad, O. C. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800051m · Cited by 3,699
Core/Shell Nanoparticles: Classes, Properties, Synthesis Mechanisms, Characterization, and Applications
Chaudhuri, R. G., & Paria, S. (2011) · Chemical Reviews · doi:10.1021/cr100449n · Cited by 3,682
The golden age: gold nanoparticles for biomedicine
Dreaden, E. C., Alkilany, A. M., Huang, X., Murphy, C. J., & El‐Sayed, M. A. (2011) · Chemical Society Reviews · doi:10.1039/c1cs15237h · Cited by 3,659

Show all 94 references

Research works printed but not linked: 2

Duncan R, Sat YN. Tumour targeting by enhanced permeability and retention (EPR) effect. Ann Oncol. 1998;9:39. · DOI
Cures P. Neglected disease research and development: is the global financial crisis changing R&D. London: Policy Cures; 2011.

Sorted by citations

Items 801–900 of 1,006

Peptide-nanoparticle conjugates as a theranostic platform
Kim, S., No, Y. H., Sluyter, R., Konstantinov, K., Kim, J. H., & Kim, J. H. (2023) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2023.215530 · Cited by 46
Therapeutic synthetic and natural materials for immunoengineering
Slezak, A., Chang, K., Hossainy, S., Mansurov, A., Rowan, S. J., Hubbell, J. A., & Guler, M. O. (2024) · Chemical Society Reviews · doi:10.1039/d3cs00805c · Cited by 44
Targeting macrophages with multifunctional nanoparticles to detect and prevent atherosclerotic cardiovascular disease
Nankivell, V. A., Vidanapathirana, A. K., Hoogendoorn, A., Tan, J. T. M., Verjans, J. W. H., Psaltis, P. J., Hutchinson, M. R., Gibson, B. C., Lu, Y., Goldys, E. M., et al. (2024) · Cardiovascular Research · doi:10.1093/cvr/cvae099 · Cited by 44
Bleomycin-Loaded pH-Sensitive Polymer–Lipid-Incorporated Liposomes for Cancer Chemotherapy
Yuba, E., Osaki, T., Ono, M., Park, S., Harada, A., Yamashita, M., Azuma, K., Tsuka, T., Ito, N., Imagawa, T., et al. (2018) · Polymers · doi:10.3390/polym10010074 · Cited by 42
Gold Nanoparticle Uptake in Tumor Cells: Quantification and Size Distribution by sp-ICPMS
Noireaux, J., Grall, R., Hullo, M., Chevillard, S., Oster, C., Brun, É., Sicard‐Roselli, C., Loeschner, K., & Fisicaro, P. (2019) · Separations · doi:10.3390/separations6010003 · Cited by 42
Augmenting the synergies of chemotherapy and immunotherapy through drug delivery
Kim, J., Manspeaker, M. P., & Thomas, S. N. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.02.012 · Cited by 42
In vivo Studies on Pharmacokinetics, Toxicity and Immunogenicity of Polyelectrolyte Nanocapsules Functionalized with Two Different Polymers: Poly-L-Glutamic Acid or PEG
Karabasz, A., Szczepanowicz, K., Cierniak, A., Mężyk-Kopeć, R., Dyduch, G., Szczęch, M., Bereta, J., & Bzowska, M. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s230865 · Cited by 42
Direct Quantification of Drug Loading Content in Polymeric Nanoparticles by Infrared Spectroscopy
Carissimi, G., Montalbán, M. G., Víllora, G., & Barth, A. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12100912 · Cited by 42
Engineered biomimetic micro/nano-materials for tissue regeneration
Han, F., Meng, Q., Xie, E., Li, K., Hu, J., Chen, Q., Li, J., & Han, F. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1205792 · Cited by 45
Secured delivery of basic fibroblast growth factor using human serum albumin-based protein nanoparticles for enhanced wound healing and regeneration
Son, B., Kim, M., Won, H., Jung, A., Kim, J., Koo, Y., Lee, N. K., Baek, S.-H., Han, U., Park, C. G., et al. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-02053-4 · Cited by 41
Medical importance and pharmacokinetics of gold nanoparticles in the human body
Singh, P., Joshi, A. S., Singh, H., & Mijakovic̀, I. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02418-3 · Cited by 47
Advances in the clinical translation of nanotechnology
Scheinberg, D. A., Grimm, J., Heller, D. A., Stater, E. P., Bradbury, M. S., & McDevitt, M. R. (2017) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2017.01.002 · Cited by 40
Co association of mucus modulating agents and nanoparticles for mucosal drug delivery
Nordgård, C. T., & Draget, K. I. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.01.001 · Cited by 41
Overcoming tumor cell chemoresistance using nanoparticles: lysosomes are beneficial for (stearoyl) gemcitabine-incorporated solid lipid nanoparticles
Chen, Z., Zheng, Y., Shi, Y.-X., & Cui, Z. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s149196 · Cited by 41
Environmental friendly synthesis of zinc oxide nanoparticles and estimation of its larvicidal activity against Aedes aegypti
Roopan, S. M., Mathew, R. S., Mahesh, S. S., Titus, D., Aggarwal, K., Bhatia, N., Damodharan, K. I., Elumalai, K., & Samuel, E. J. J. (2018) · International Journal of Environmental Science and Technology · doi:10.1007/s13762-018-2175-z · Cited by 41
Nanoscaled Dispersed Systems Used in Drug-Delivery Applications
Cheaburu-Yılmaz, C. N., Karasulu, H. Y., & Yılmaz, O. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813932-5.00013-3 · Cited by 44
Cytotoxicity, cellular uptake and apoptotic responses in human coronary artery endothelial cells exposed to ultrasmall superparamagnetic iron oxide nanoparticles
Palacios-Hernández, T., Diaz-Diestra, D., Nguyen, A. K., Skoog, S. A., Chikkaveeraiah, B. V., Tang, X., Wu, Y. C., Petrochenko, P. E., Sussman, E. M., & Goering, P. L. (2020) · Journal of Applied Toxicology · doi:10.1002/jat.3953 · Cited by 39
Silver Nanoparticles Agglomerate Intracellularly Depending on the Stabilizing Agent: Implications for Nanomedicine Efficacy
Mulenos, M. R., Lujan, H., Pitts, L. R., & Sayes, C. M. (2020) · Nanomaterials · doi:10.3390/nano10101953 · Cited by 41
Biomimetic bacterial and viral-based nanovesicles for drug delivery, theranostics, and vaccine applications
Loo, Y. S., Bose, R. J., McCarthy, J. R., Azmi, I. D. M., & Madheswaran, T. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.12.017 · Cited by 42
Molecular Imaging in Nanotechnology and Theranostics
Andreou, C., Pal, S., Rotter, L. K., Jiang, Y., & Kircher, M. F. (2017) · Molecular Imaging and Biology · doi:10.1007/s11307-017-1056-z · Cited by 42
Novel poly (2-oxazoline) block copolymer with aromatic heterocyclic side chains as a drug delivery platform
Hwang, D., Ramsey, J. D., Makita, N., Sachse, C., Jordan, R., Sokolsky-Papkov, M., & Kabanov, A. V. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.06.037 · Cited by 40
Current Advances in Nanotheranostics for Molecular Imaging and Therapy of Cardiovascular Disorders
Setia, A., Mehata, A. K., Priya, V., Pawde, D. M., Jain, D., Mahto, S. K., & Muthu, M. S. (2023) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.3c00582 · Cited by 42
Superparamagnetic Iron Oxide Nanoparticles in Musculoskeletal Biology
Iyer, S. R., Xu, S., Stains, J. P., Bennett, C., & Lovering, R. M. (2016) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2016.0437 · Cited by 39
Single step formation of biocompatible bimetallic alloy nanoparticles of gold and silver using isonicotinylhydrazide
Navya, P. N., Madhyastha, H., Madhyastha, R., Nakajima, Y., Maruyama, M., Srinivas, S. P., Jain, D., Amin, M. H., Bhargava, S. K., & Daima, H. K. (2018) · Materials Science and Engineering C · doi:10.1016/j.msec.2018.11.024 · Cited by 40
Engineered microparticles and nanoparticles for fibrinolysis
Disharoon, D., Marr, D. W. M., & Neeves, K. B. (2019) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14637 · Cited by 40
Protein drug delivery: current dosage form profile and formulation strategies
Geraldes, D. C., Beraldo-de-Araújo, V. L., Pardo, B. O. P., Pessoa, A., Stephano, M. A., & Nascimento, L. D. O. (2019) · Journal of drug targeting · doi:10.1080/1061186x.2019.1669043 · Cited by 40
The use of hydrogel-delivered extracellular vesicles in recovery of motor function in stroke: a testable experimental hypothesis for clinical translation including behavioral and neuroimaging assessment approaches
Makris, N., Tsintou, M., Dalamagkas, K., Moore, T. L., Yogesh Rathi, A., Kubicki, M. R., & Rosene, D. L. (2020) · Neural Regeneration Research · doi:10.4103/1673-5374.295269 · Cited by 40
Technological approaches to streamline vaccination schedules, progressing towards single-dose vaccines
Lofano, G., Mallett, C. P., Bertholet, S., & O’Hagan, D. T. (2020) · npj Vaccines · doi:10.1038/s41541-020-00238-8 · Cited by 41
Homing Peptides for Cancer Therapy
Lingasamy, P., & Teesalu, T. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-58174-9_2 · Cited by 42
Role of Anisotropy, Frequency, and Interactions in Magnetic Hyperthermia Applications: Noninteracting Nanoparticles and Linear Chain Arrangements
Valdés, D. P., Lima, E., Zysler, R. D., Goya, G. F., & Biasi, E. D. (2021) · Physical Review Applied · doi:10.1103/physrevapplied.15.044005 · Cited by 40
Implications of biomimetic nanocarriers in targeted drug delivery
Al‐Hetty, H. R. A. K., Kadhim, M. S., Al-Tamimi, J. H. Z., Ahmed, N. M., Jalil, A. T., Saleh, M. M., Kandeel, M. K., & Abbas, R. H. (2023) · Emergent Materials · doi:10.1007/s42247-023-00453-8 · Cited by 41
Bioimaging guided pharmaceutical evaluations of nanomedicines for clinical translations
Tuguntaev, R. G., Hussain, A., Fu, C., Chen, H., Tao, Y., Huang, Y. H., Liu, L., Liang, X., & Guo, W. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01451-4 · Cited by 41
Regulatory T-cells: The Face-off of the Immune Balance
Singer, M., Elsayed, A. M., & Husseiny, M. I. (2024) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2911377 · Cited by 44
Polymer-Based Nanocarriers for Co-Delivery and Combination of Diverse Therapies against Cancers
Yan, G., Li, A., Zhang, A., Sun, Y. Y., & Liu, J. (2018) · Nanomaterials · doi:10.3390/nano8020085 · Cited by 39
Lactoferrin-modified Betulinic Acid-loaded PLGA nanoparticles are strong anti-leishmanials
Halder, A., Shukla, D., Das, S., Roy, P., Mukherjee, A., & Saha, B. (2018) · Cytokine · doi:10.1016/j.cyto.2018.05.010 · Cited by 39
Characterization of drug delivery vehicles using atomic force microscopy: current status
Smith, J. R., Olusanya, T. O. B., & Lamprou, D. A. (2018) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2018.1546693 · Cited by 38
Recent Advances in Engineering of Lipid Drug Conjugates for Cancer Therapy
Sreekanth, V., & Bajaj, A. (2019) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.9b00689 · Cited by 39
Engineered Polymeric Materials for Biological Applications: Overcoming Challenges of the Bio–Nano Interface
Simpson, J. D., Smith, S. A., Thurecht, K. J., & Such, G. K. (2019) · Polymers · doi:10.3390/polym11091441 · Cited by 40
Self-citation
Effect on Platelet Function of Metal-Based Nanoparticles Developed for Medical Applications
Hante, N. K., Medina, C., & Santos-Martínez, M. J. (2019) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2019.00139 · Cited by 40
Nanoparticles and organized lipid assemblies: from interaction to design of hybrid soft devices
Mendozza, M., Caselli, L., Salvatore, A., Montis, C., & Berti, D. (2019) · Soft Matter · doi:10.1039/c9sm01601e · Cited by 39
Synchronizing In Silico , In Vitro , and In Vivo Studies for the Successful Nose to Brain Delivery of an Anticancer Molecule
Abd-algaleel, S. A., Metwally, A. A., Abdel‐Bar, H. M., Kassem, D. H., & Hathout, R. M. (2021) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.1c00276 · Cited by 39
Molecular Switches—Tools for Imparting Control in Drug Delivery Systems
Fitzmaurice, O., Bartkowski, M., & Giordani, S. (2022) · Frontiers in Chemistry · doi:10.3389/fchem.2022.859450 · Cited by 39
Anticancer Applications of Essential Oils Formulated into Lipid-Based Delivery Nanosystems
Jampílek, J., & Kráľová, K. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14122681 · Cited by 45
pH-triggered cancer-targeting polymers: From extracellular accumulation to intracellular release
Khan, R. U., Shao, J., Liao, J., & Qian, L. (2023) · Nano Research · doi:10.1007/s12274-022-5252-z · Cited by 39
Breaking Barriers: Bioinspired Strategies for Targeted Neuronal Delivery to the Central Nervous System
Spencer, A. P., Torrado, M., Custódio, B., Silva-Reis, S. C., Santos, S. D., Leiro, V., & Pêgo, A. P. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12020192 · Cited by 40
Lipid based drug delivery systems for oral, transdermal and parenteral delivery: Recent strategies for targeted delivery consistent with different clinical application
Srivastav, A. K., Karpathak, S., Rai, M. K., Kumar, D., Misra, D. P., & Agarwal, V. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.104526 · Cited by 40
Exploring the Potential of Nanogels: From Drug Carriers to Radiopharmaceutical Agents
Kubeil, M., Suzuki, Y., Casulli, M. A., Kamal, R., Hashimoto, T., Bachmann, M. P., Hayashita, T., & Stephan, H. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202301404 · Cited by 39
Bio-nanomaterials: Promising anticancer properties and treatment strategies
Elemike, E. E., Onunkwo, I. C., Ughumiakpor, O., Alawuru, F., Mukoro, A., Ishom, P., Obarakpor, F., Hossain, I., & Aziza, A. E. (2025) · Nano TransMed · doi:10.1016/j.ntm.2025.100076 · Cited by 42
A Near‐Infrared Responsive Drug Sequential Release System for Better Eradicating Amyloid Aggregates
Ma, M., Gao, N., Sun, Y., Ren, J., & Qu, X. (2017) · Small · doi:10.1002/smll.201701817 · Cited by 38
Reduction of liver fibrosis by rationally designed macromolecular telmisartan prodrugs
Golder, M. R., Liu, J. X., Andersen, J. N., Shipitsin, M. V., Vohidov, F., Nguyen, H. V. ‐., Ehrlich, D. C., Huh, S. J., Vangamudi, B., Economides, K. D., et al. (2018) · Nature Biomedical Engineering · doi:10.1038/s41551-018-0279-x · Cited by 38
Influence of Charge on Hemocompatibility and Immunoreactivity of Polymeric Nanoparticles
Chen, L., Glass, J. J., Rose, R. D., Sperling, C., Kent, S. J., Houston, Z. H., Fletcher, N. L., Rolfe, B. E., & Thurecht, K. J. (2018) · ACS Applied Bio Materials · doi:10.1021/acsabm.8b00220 · Cited by 39
Self-citation
Exploiting Nanomaterial‐Mediated Autophagy for Cancer Therapy
Wei, W., Rosenkrans, Z. T., Luo, Q., Lan, X., & Cai, W. (2018) · Small Methods · doi:10.1002/smtd.201800365 · Cited by 41
Effect of Cell Age on Uptake and Toxicity of Nanoparticles: The Overlooked Factor at the Nanobio Interface
Foroozandeh, P., Aziz, A. A., & Mahmoudi, M. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b15533 · Cited by 38
Reductive Stress, Bioactive Compounds, Redox-Active Metals, and Dormant Tumor Cell Biology to Develop Redox-Based Tools for the Treatment of Cancer
Quiles, J. L., Sánchez‐González, C., Ramírez, L. V., Giampieri, F., Navarro‐Hortal, M. D., Xiao, J., Llopis, J., Battino, M. A., & Varela‐López, A. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8051 · Cited by 39
Polymer nanoparticle-assisted chemotherapy of pancreatic cancer
Su, T., Yang, B., Gao, T., Liu, T., & Li, J. (2020) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835920915978 · Cited by 38
Progressive lysosomal membrane permeabilization induced by iron oxide nanoparticles drives hepatic cell autophagy and apoptosis
Levada, K. V., Pshenichnikov, S. E., Omelyanchik, A. S., Rodionova, V. V., Nikitin, A. A., Савченко, А. Г., Щетинин, И. В., Zhukov, D., Abakumov, M. A., Majouga, A. G., et al. (2020) · Nano Convergence · doi:10.1186/s40580-020-00228-5 · Cited by 38
Rational nanocarrier design towards clinical translation of cancer nanotherapy
Guo, D., Ji, X., & Luo, J. (2021) · Biomedical Materials · doi:10.1088/1748-605x/abe35a · Cited by 39
Quantum Dot Nanomedicine Formulations Dramatically Improve Pharmacological Properties and Alter Uptake Pathways of Metformin and Nicotinamide Mononucleotide in Aging Mice
Hunt, N. J., Lockwood, G. P., Kang, S. W. S., Westwood, L. J., Limantoro, C., Chrzanowski, W., McCourt, P., Kuncic, Z., Couteur, D. G. L., & Cogger, V. C. (2021) · ACS Nano · doi:10.1021/acsnano.0c09278 · Cited by 38
The Emerging Role of Topical Ocular Drugs to Target the Posterior Eye
Wang, L., Zhou, M., & Zhang, H. (2021) · Ophthalmology and Therapy · doi:10.1007/s40123-021-00365-y · Cited by 43
Interplay between nanomedicine and protein corona
Yang, M., Wu, E., Tang, W., Qian, J., & Zhan, C. (2021) · Journal of Materials Chemistry B · doi:10.1039/d1tb01063h · Cited by 40
Long-Term Clearance and Biodistribution of Magnetic Nanoparticles Assessed by AC Biosusceptometry
Soares, G. A., Faria, J. V. C., Pinto, L. A., Prospero, A. G., Pereira, G. M., Stoppa, E. G., Buranello, L. P., Bakuzis, A. F., Baffa, O., & Miranda, J. R. D. A. (2022) · Materials · doi:10.3390/ma15062121 · Cited by 44
Theranostic magnetic nanoparticles enhance DNA damage and mitigate doxorubicin-induced cardio-toxicity for effective multi-modal tumor therapy
Shetake, N. G., Ali, M., Kumar, A., Bellare, J., & Pandey, B. N. (2022) · Biomaterials Advances · doi:10.1016/j.bioadv.2022.213147 · Cited by 38
Microfluidic approaches for producing lipid-based nanoparticles for drug delivery applications
Piunti, C., & Cimetta, E. (2023) · Biophysics Reviews · doi:10.1063/5.0150345 · Cited by 37
Mapping hair follicle-targeted delivery by particle systems: What has science accomplished so far?
Costa, C., Cavaco-Paulo, A. M., & Matamá, T. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.121273 · Cited by 37
Role of siRNA-based nanocarriers for the treatment of neurodegenerative diseases
Mishra, N., Ashique, S., Garg, A., Rai, V. K., Dua, K., Goyal, A. K., & Bhatt, S. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.01.003 · Cited by 37
Engineering zinc oxide hybrid selenium nanoparticles for synergetic anti-tuberculosis treatment by combining Mycobacterium tuberculosis killings and host cell immunological inhibition
Lin, W., Fan, S., Liao, K., Huang, Y., Cong, Y., Zhang, J., Jin, H., Zhao, Y., Ruan, Y., Lu, H., et al. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.1074533 · Cited by 37
Carbon Dots‐Cluster‐DOX Nanocomposites Fabricated by a Co‐Self‐Assembly Strategy for Tumor‐Targeted Bioimaging and Therapy
Deng, T., Zhang, R., Wang, J., Song, X., Bao, F., Gu, Y., & Deng, D. (2018) · Particle & Particle Systems Characterization · doi:10.1002/ppsc.201800190 · Cited by 37
Biodistribution and biocompatibility of passion fruit-like nano-architectures in zebrafish
d’Amora, M., Cassano, D., Pocoví‐Martínez, S., Giordani, S., & Voliani, V. (2018) · Nanotoxicology · doi:10.1080/17435390.2018.1498551 · Cited by 37
Nanoparticle-mediated magnetic hyperthermia is an effective method for killing the human-infective protozoan parasite Leishmania mexicana in vitro
Berry, S. L., Walker, K., Hoskins, C., Telling, N. D., & Price, H. P. (2019) · Scientific Reports · doi:10.1038/s41598-018-37670-9 · Cited by 37
Mesoporous silica-based hybrid materials for bone-specific drug delivery
Pasqua, L., Napoli, I. E. D., Santo, M. D., Greco, M., Catizzone, E., Lombardo, D., Montera, G., Comandé, A., Nigro, A., Morelli, C., et al. (2019) · Nanoscale Advances · doi:10.1039/c9na00249a · Cited by 37
Rational design and facile fabrication of biocompatible triple responsive dendrimeric nanocages for targeted drug delivery
Zhong, D., Wu, H., Wu, Y., Yun-kun, L., Xu, X., Yang, J., & Gu, Z. (2019) · Nanoscale · doi:10.1039/c9nr04631c · Cited by 37
Fabricating β-cyclodextrin based pH-responsive nanotheranostics as a programmable polymeric nanocapsule for simultaneous diagnosis and therapy
Zarepour, A., Zarrabi, A., & Larsen, K. L. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s221598 · Cited by 37
Ultrasmall PEGylated and Targeted Core–Shell Silica Nanoparticles Carrying Methylene Blue Photosensitizer
Kohle, F. F. E., Li, S., Turker, M. Z., & Wiesner, U. B. (2019) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.9b01359 · Cited by 37
PLGA protein nanocarriers with tailor-made fluorescence/MRI/PET imaging modalities
Zhang, Y., García‐Gabilondo, M., Grayston, A., Feiner, I. V. J., Anton‐Sales, I., Loiola, R. A., Llop, J., Ramos‐Cabrer, P., Barba, I., David Garcia-dorado, A., et al. (2020) · Nanoscale · doi:10.1039/c9nr10620k · Cited by 37
Comparative whole corona fingerprinting and protein adsorption thermodynamics of PLGA and PCL nanoparticles in human serum
Ndumiso, M., Buchtová, N., Hüsselmann, L., Mohamed, G., Klein, A., Aucamp, M. E., Canevet, D., D’Souza, S., Maphasa, R. E., Boury, F., et al. (2020) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2020.110816 · Cited by 37
pH-Responsive nanocomposite fibres allowing MRI monitoring of drug release
Zhang, Z., Wells, C. J. R., King, A. M., Bear, J. C., Davies, G., & Williams, G. R. (2020) · Journal of Materials Chemistry B · doi:10.1039/d0tb01033b · Cited by 37
Non-Heating Alternating Magnetic Field Nanomechanical Stimulation of Biomolecule Structures via Magnetic Nanoparticles as the Basis for Future Low-Toxic Biomedical Applications
Golovin, Y. I., Golovin, D. Y., Vlasova, K. Y., Veselov, M. M., Usvaliev, A. D., Kabanov, A. V., & Klyachko, N. L. (2021) · Nanomaterials · doi:10.3390/nano11092255 · Cited by 38
Microneedle-mediated delivery of MIL-100(Fe) as a tumor microenvironment-responsive biodegradable nanoplatform for O 2 -evolving chemophototherapy
Luo, S., Zhao, Y., Pan, K., Zhou, Y., Quan, G., Wen, X., Pan, X., & Wu, C. (2021) · Biomaterials Science · doi:10.1039/d1bm00888a · Cited by 37
Facets of ICP-MS and their potential in the medical sciences—Part 2: nanomedicine, immunochemistry, mass cytometry, and bioassays
Clases, D., & de Vega, R. G. (2022) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-022-04260-8 · Cited by 40
Nanoparticles as a Therapeutic Delivery System for Skin Cancer Prevention and Treatment
Chang, J., Yu, B., Saltzman, W. M., & Girardi, M. (2023) · JID Innovations · doi:10.1016/j.xjidi.2023.100197 · Cited by 37
Tumor microenvironment remodeling in oral cancer: Application of plant derived-natural products and nanomaterials
Budi, H. S., & Farhood, B. (2023) · Environmental Research · doi:10.1016/j.envres.2023.116432 · Cited by 40
Targeted delivery strategies: The interactions and applications of nanoparticles in liver diseases
Meng, X., Zhu, G., Yang, Y., & Sun, T. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116702 · Cited by 40
Thermoresponsive Pegylated Bubble Liposome Nanovectors for Efficient siRNA Delivery Via Endosomal Escape
Alamoudi, K. O., Martins, P. A. T., Croissant, J. G., Patil, S. P., Omar, H. W., & Khashab, N. M. (2017) · Nanomedicine · doi:10.2217/nnm-2017-0021 · Cited by 36
Uptake and transport of pullulan acetate nanoparticles in the BeWo b30 placental barrier cell model
Tang, H., Jiang, Z., He, H., Li, X., Hu, H., Zhang, N., Dai, Y., & Zhou, Z. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s161319 · Cited by 36
Naturally Occurring Bioactive Compound‐Derived Nanoparticles for Biomedical Applications
Saw, P. E., Lee, S., & Jon, S. (2019) · Advanced Therapeutics · doi:10.1002/adtp.201800146 · Cited by 36
Enhanced drug internalization and therapeutic efficacy of PEGylated nanoparticles by one-step formulation with anti-mPEG bispecific antibody in intrinsic drug-resistant breast cancer
Cheng, Y., Chen, I., Su, Y.-C., Cheng, K.-W., Lu, Y., Lin, W.-W., Hsieh, Y.-C., Kao, C.-H., Chen, F., Roffler, S. R., et al. (2019) · Biomaterials Science · doi:10.1039/c9bm00323a · Cited by 36
A pH-sensitive fluorescent protein sensor to follow the pathway of calcium phosphate nanoparticles into cells
Kollenda, S., Kopp, M., Wens, J., Koch, J., Schulze, N., Papadopoulos, C., Pöhler, R., Meyer, H. H., & Epple, M. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.05.014 · Cited by 35
Reactive Oxygen Species-Responsive Liposomes via Boronate-Caged Phosphatidylethanolamine
Lou, J., & Best, M. D. (2020) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.0c00397 · Cited by 37
Bowl-Shaped Mesoporous Polydopamine Nanoparticles for Size-Dependent Endocytosis into HeLa Cells
Acter, S., Vidallon, M. L. P., Crawford, S., Tabor, R. F., & Teo, B. M. (2021) · ACS Applied Nano Materials · doi:10.1021/acsanm.1c01897 · Cited by 36
Applications of nanotechnology in biological systems and medicine
Zain, M., Yasmeen, H., Yadav, S. S., Amir, S., Bilal, M., Shahid, A., & Khurshid, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823971-1.00019-2 · Cited by 36
Near infrared light activated upconversion nanoparticles (UCNP) based photodynamic therapy of prostate cancers: An in vitro study
Güleryüz, B., Ünal, U., & Gülsoy, M. (2021) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2021.102616 · Cited by 36
Theranostic Nanomedicines for the Treatment of Cardiovascular and Related Diseases: Current Strategies and Future Perspectives
Manners, N., Priya, V., Mehata, A. K., Rawat, M., Mohan, S., Makeen, H. A., Albratty, M., Albarrati, A., Meraya, A. M., & Muthu, M. S. (2022) · Pharmaceuticals · doi:10.3390/ph15040441 · Cited by 40
Poly(Glycerol)-Based Biomedical Nanodevices Constructed by Functional Programming on Inorganic Nanoparticles for Cancer Nanomedicine
Komatsu, N. (2023) · Accounts of Chemical Research · doi:10.1021/acs.accounts.2c00615 · Cited by 36
Nano-Gels: Recent Advancement in Fabrication Methods for Mitigation of Skin Cancer
Alotaibi, G., Alharthi, S., Basu, B., Ash, D., Dutta, S., Singh, S. K., Prajapati, B. G., Bhattacharya, S., Chidrawar, V. R., & Chitme, H. R. (2023) · Gels · doi:10.3390/gels9040331 · Cited by 38
Translational challenges in advancing regenerative therapy for treating neurological disorders using nanotechnology
Nemeth, C. L., Fine, A. S., & Fatemi, A. S. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.05.003 · Cited by 37
Translating controlled release systems from biomedicine to agriculture
Lee, P., Lin, X., Khan, F. N., Bennett, A. E., & Winter, J. O. (2022) · Frontiers in Biomaterials Science · doi:10.3389/fbiom.2022.1011877 · Cited by 41
Targeting diffuse midline gliomas: The promise of focused ultrasound-mediated blood-brain barrier opening
Martinez, P. J., Green, A. L., & Borden, M. A. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.11.037 · Cited by 38
Nanotechnology-based drug delivery system for the diagnosis and treatment of ovarian cancer
Saripilli, R., & Sharma, D. K. (2025) · Discover Oncology · doi:10.1007/s12672-025-02062-9 · Cited by 38
A journey through the emergence of nanomedicines with poly(alkylcyanoacrylate) based nanoparticles
Vauthier, C. (2019) · Journal of drug targeting · doi:10.1080/1061186x.2019.1588280 · Cited by 37
Dye-doped biodegradable nanoparticle SiO 2 coating on zinc- and iron-oxide nanoparticles to improve biocompatibility and for in vivo imaging studies
Navarro-Palomares, E., González-Saiz, P., Renero‐Lecuna, C., Martín‐Rodríguez, R., Aguado, F., González‐Alonso, D., Barquín, L. F., González, J., Bañobre‐López, M., Fanárraga, M. L., et al. (2020) · Nanoscale · doi:10.1039/c9nr08743e · Cited by 36

Authors: Bobo, D., Robinson, K. J., Islam, J., Thurecht, K. J., & Corrie, S. R.
Affiliations: The University of Queensland (AU)
Monash University (AU)
Corresponding author: Corrie, Simon R.
ORCID: Bobo, Daniel
Robinson, Kye J.
Thurecht, Kristofer J.
Corrie, Simon R.
Venue: Pharmaceutical Research
Publisher: Springer Science and Business Media LLC
Published: 2016-06-14
Volume: 33
Issue: 10
Pages: 2373-2387
ISSN: 0724-8741 (ISSN-L)
1573-904X
DOI: 10.1007/s11095-016-1958-5
OpenAlex: W2421275313
Cited by: 2,586
References: 94
Citations by year: 2026: 173 · 2025: 202 · 2024: 218 · 2023: 250 · 2022: 302 · 2021: 382 · 2020: 391 · 2019: 323 · 2018: 234 · 2017: 96 · 2016: 12
FWCI: 11.86
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Pharmaceutical Research (publishedVersion)
PubMed (publishedVersion)
Funders: Centre of Excellence in Convergent BioNano Science and Technology (CE140100036)
National Health and Medical Research Council (APP1099231)
Australian Research Council (FT110100284, DP140100951)
Topics: Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
Physical Sciences › Materials Science › General Materials Science › Nanotechnology research and applications
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
Keywords: nanomedicine, nanoparticle drug delivery, liposomes, polymeric nanoparticles, nanocrystals, micelles, protein nanoparticles, inorganic nanoparticles, metal nanoparticles, theranostics, active targeting, nanomaterial classification, regulatory approval
MeSH terms: Clinical Trials as Topic, Humans, Tissue Distribution, United States, Drug Approval, Nanomedicine, Nanoparticles

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks